$FTRP News
Last published 4y ago
- 4y agoFTRPReunion Neuroscience Inc. to Commence Trading on the Toronto Stock Exchange on August 17, 2022GlobeNewswireTORONTO, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (formerly, Field Trip Health Ltd., the "Company" or "Reunion"), a global leader in the discovery and development of innovative of psychedelic-inspired therapeutics for improved mental
- 4y agoFTRPReunion Neuroscience Inc. (Formerly Field Trip Health Ltd.) Reports Fiscal First Quarter 2023 Financial Results, Completed Corporate Reorganization on August 11, 2022GlobeNewswireCompleted corporate reorganization, separating the Field Trip Discovery and Field Trip Health divisions into two separate companies. Field Trip Discovery renamed Reunion Neuroscience Inc. ("Reunion" or the "Company"), and will remain listed on the NASD
- 4y agoFTRPField Trip Announces Closing of Plan of Arrangement and $19.9 Million Private Placement FinancingGlobeNewswire- Field Trip Health Ltd. has been renamed "Reunion Neuroscience Inc." and remains listed on the NASDAQ Stock Market and Toronto Stock Exchange under the ticker symbol "FTRP" with such ticker symbol changing to "REUN"- Field Trip Health & Wellness Ltd. to
- 4y agoFTRPField Trip Health Ltd. Schedules Fiscal First Quarter 2023 Conference Call for Tuesday, August 16, 2022, at 8:30 AM ETGlobeNewswireTORONTO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX:FTRP, NASDAQ:FTRP) ("Field Trip" or the "Company"), a global leader in the development and delivery of psychedelic therapies, announced today that it plans to release financial resu
- 4y agoFTRPField Trip Health Ltd. Receives Conditional Approval for Listing of Common Shares of Field Trip Health & Wellness Ltd. on the TSX Venture ExchangeGlobeNewswire– Field Trip Health & Wellness Ltd. to list on the TSX Venture Exchange, with first day of trading expected to occur on or about August 17, 2022. – Field Trip Discovery to be renamed Reunion Neuroscience Inc., remaining listed on the NASDAQ Stock
- 4y agoATAICMPSCYBNENTBF+2Ketamine Ushering in New Era in the Pharmacology Therapies for Neurological DisordersPR NewswireFinancialNewsMedia.com News Commentary PALM BEACH, Fla., July 27, 2022 /PRNewswire/ -- For years, ketamine was known for its use as an anesthetic or as a recreational drug. Its ability to provide quick and safe sedation saved many lives during the Vie
- 4y agoFTRPField Trip Announces First Dosings in Phase I Clinical Study of FT-104GlobeNewswire- First Dosings completed in Australia- Provides Update on Pending Spin-Out and Renaming to Reunion Neurosciences- Announces 5:1 Share Consolidation Ratio TORONTO, July 21, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX:FTRP, FTRP.WT, NASDAQ:F
- 4y agoFTRPField Trip Health Ltd. Reports Fiscal Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update Including Corporate ReorganizationGlobeNewswireCompleted strategic review and announced intention to separate the Field Trip Discovery and Field Trip Health divisions into two independent public companies. Earned patient services revenues of $1.7 million in fiscal fourth quarter, an increase of 26.
- 4y agoFTRPField Trip Health Ltd. Receives Final Court Approval for Reorganization of the Discovery and Wellness Businesses Into Two Publicly Traded CompaniesGlobeNewswire- Closing of arrangement subject to regulatory approvals, including conditional listing approval by the TSX Venture Exchange.- Closing of the arrangement expected to occur in August.- Also announces closing of subscription receipt offering. TORONTO,
- 4y agoFTRPField Trip Health Ltd. Announces Voting Results From Special Shareholder MeetingGlobeNewswireTORONTO, June 27, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX:FTRP, FTRP.WT, NASDAQ:FTRP) ("Field Trip" or "Corporation"), a global leader in the development and delivery of psychedelic therapies, today announced that on June 27, 2022, its sha
- 4y agoFTRPField Trip Health Ltd. to Present at the H.C. Wainwright 1st Annual Mental Healthcare Conference on June 27, 2022GlobeNewswireTORONTO, June 23, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX:FTRP, FTRP.WT, NASDAQ:FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that Field Trip's Co-founder and Executive Chai
- 4y agoFTRPField Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year 2022 Results Conference Call for Thursday, June 30, 2022 at 8:30 AM ETGlobeNewswireTORONTO, June 22, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX:FTRP, FTRP.WT, NASDAQ:FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that it plans to release financial results for
- 4y agoFTRPField Trip Health Ltd. Announces Increased Participation in Arrangement Financing and Postponement of Shareholder Meeting DateGlobeNewswireTORONTO, June 14, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX:FTRP, FTRP.WT, NASDAQ:FTRP) (the "Company" or "Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that it has agreed to increase
- 4y agoFTRPField Trip and Nue Life Are Collaborating To Bring Psychedelic Therapy Into the HomeGlobeNewswireTORONTO, May 12, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (NASDAQ:FTRP, TSX:FTRP) ("Field Trip"), a leader in the development and delivery of psychedelic-assisted psychotherapy with 12 locations across North America and Europe, and Nue Life Heal
- 4y agoASTSBLBXBPFTRP+1Thinking about buying stock in AST SpaceMobile, Blackboxstocks, Field Trip Health, BP, or Harbor Custom Development?PR NewswireNEW YORK, May 3, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ASTS, BLBX, FTRP, BP, and HCDI. To s
- 4y agoFTRPField Trip Health Ltd. to Participate in Upcoming Investor Conferences in May 2022GlobeNewswireTORONTO, April 29, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX:FTRP, FTRP.WT, NASDAQ:FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that Field Trip's management team will partici
- 4y agoFTRPField Trip Health Ltd. Announces Intention to Separate the Field Trip Discovery and Field Trip Health Divisions Into Two Independent Public CompaniesGlobeNewswireTransaction will create two distinct emerging leaders in the psychedelics industry, one providing personalized care and the other developing next generation psychedelic therapies. Shareholders of Field Trip will receive shares of each company.
- 4y agoFTRPField Trip Health Ltd. to Participate in Upcoming Investor ConferencesGlobeNewswireTORONTO, April 18, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX:FTRP, FTRP.WT, NASDAQ:FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that Field Trip's management team will partici
- 4y agoFTRPField Trip Health Ltd. Granted US Patent Covering Novel Psychedelic Molecule FT-104GlobeNewswireTORONTO, April 05, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (NASDAQ:FTRP, TSX:FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, today announced that the U.S. Patent and Trademark Office ("USPTO") has
- 4y agoFTRPField Trip Health Ltd. to Participate in Maxim Group 2nd Annual Virtual Growth ConferenceGlobeNewswireTORONTO, March 23, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX:FTRP, FTRP.WT, NASDAQ:FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that management will present at the Maxim Grou
- 4y agoFTRPField Trip Health Ltd. to Participate in 34th Annual Roth Conference in March 2022GlobeNewswireTORONTO, March 09, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX:FTRP, FTRP.WT, NASDAQ:FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that management will be presenting at the 34th
- 4y agoATAICYBNENVBFTRP+3Benzinga Expands Footprint into the Psychedelic Industry with the Launch of the Benzinga Psychedelic Advisory CouncilPR NewswireDETROIT, March 4, 2022 /PRNewswire/ -- The Benzinga Psychedelics Advisory Council is a collective of the leading minds and voices in the psychedelics space, composed of key thought leaders sharing insights into industry developments, sector trends and br
- 4y agoFTRPField Trip Health and Cerebral Partner to Provide End-to-End Mental Health CarePR NewswireTORONTO, March 3, 2022 /PRNewswire/ -- Field Trip Health Ltd. (NASDAQ:FTRP, TSX:FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic-assisted psychotherapy, today announced a strategic partnership with Cerebral, the fastes
- 4y agoFTRPField Trip Health Ltd. Reports Third Fiscal Quarter 2022 Financial Results and Provides Business UpdateGlobeNewswireEarned patient services revenues of $1,360,811, an increase of 50% over the prior quarter and 330% year over year. At December 31, 2021, Field Trip had approximately $74.5 million in unrestricted cash and cash equivalents and short-term investments. R
- 4y agoFTRPField Trip Health Ltd. Schedules Third Fiscal Quarter 2022 Financial Results Conference Call for February 16, 2022 at 8:30 AM ETGlobeNewswireTORONTO, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX:FTRP, FTRP.WT, NASDAQ:FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that it plans to release financial results for
- 4y agoFTRPField Trip Health Ltd. to Participate in Citi's Psychedelic Drug Video Call SeriesGlobeNewswireTORONTO, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX:FTRP, FTRP.WT, NASDAQ:FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that Field Trip's Co-Founder and CEO, Joseph de
- 4y agoFTRPField Trip Receives Notice of Allowance for US Patent Application Covering FT-104 (Isoprocin Glutarate), its Novel Psychedelic Molecule in DevelopmentGlobeNewswireTORONTO, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (NASDAQ:FTRP, TSX:FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, today announced that the U.S. Patent and Trademark Office (USPTO) has is
- 4y agoFTRPField Trip Announces Intention to Make Applications on Behalf of Patients to Health Canada's Special Access Program (SAP) for Access to Psilocybin and MDMA-Assisted TherapiesGlobeNewswireTORONTO, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (NASDAQ:FTRP, TSX:FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, today announced that it will begin making applications for Canadians in
- 4y agoFTRPField Trip Health Ltd. to Participate in H.C. Wainwright Bioconnect Virtual Conference in January 2022GlobeNewswireTORONTO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX:FTRP, FTRP.WT, NASDAQ:FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that Field Trip's Co-Founder and CEO, Joseph de
- 4y agoATAICMPSFTRPMCURF+1North American Psychedelic Drugs Market Expected To Reach A Value Of $3.184 Billion In 2026PR NewswirePALM BEACH, Fla., Dec. 14, 2021 /PRNewswire/ -- FinancialNewsMedia.com News Commentary - The prevalence of mental health disorders has risen exponentially, and the development of novel medications has not kept pace, precipitating a crisis in psychiatri
- 4y agoFTRPField Trip Launches Site Management Organization (SMO) Services, Hires Stéphan Côté as Head of QualityGlobeNewswireTORONTO, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (NASDAQ:FTRP, TSX:FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, today announced the launch of its Site Management Organization Services
- 4y agoFTRPField Trip Health Ltd. to Participate in Upcoming Conferences in December 2021GlobeNewswireTORONTO, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX:FTRP, FTRP.WT, NASDAQ:FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that management will present at H.C. Wainwright
- 4y agoATAICMPSCYBNFTRP+1Use of Ketamine for Mental Disorders Rising While New Therapies EmergePR NewswirePALM BEACH, Fla., Nov. 17, 2021 /PRNewswire/ -- FinancialNewsMedia.com News Commentary - The uses of Ketamine for a variety of therapies are growing. An expanding number of clinics are offering ketamine infusion therapy for the treatment of mental health
- 4y agoFTRPField Trip Health Ltd. Reports Second Fiscal Quarter 2022 Financial Results and Provides Business UpdateGlobeNewswireAnnounced plans to advance FT-104, its novel psychedelic compound, to clinic for Treatment-Resistant Depression and Postpartum Depression as the lead indications. Initiated a new pipeline research program focused on discovering novel psychedelics with
- 5y agoFTRPField Trip Health Ltd. to Participate in Upcoming Conferences in November 2021GlobeNewswireTORONTO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX:FTRP, FTRP.WT, NASDAQ:FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that during the month of November management wi
- 5y agoFTRPField Trip Health Ltd. Schedules Second Fiscal Quarter 2022 Financial Results Conference Call for Tuesday, November 16, 2021 at 8:30 AM ETGlobeNewswireTORONTO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX:FTRP, FTRP.WT, NASDAQ:FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that it plans to release financial results for
- 5y agoATAICMPSCYBNFTRP+1Breaking the Habit: Psychedelic Stigma Fades as Research Points to Critical Use in Smoking Cessation and MorePR NewswireNEW YORK, Nov. 1, 2021 /PRNewswire/ -- There isn't a cigarette smoker in the world who doesn't know smoking is bad for them. The problems are that nicotine is one of the most highly addictive substances in the world, and for the nearly 70% of 34.1 millio
- 5y agoAWKNFCYBNFTRPMCURF+1Developments with Ketamine Psychotherapy Are Driving A Medical Revolution For Treating Mental Health IssuesPR NewswirePALM BEACH, Fla., Oct. 28, 2021 /PRNewswire/ -- FinancialNewsMedia.com News Commentary - Psychedelic drugs such as psilocybin, LSD and MDMA have tremendous medical and commercial future potential… and for ketamine, the "future" is now. Drug developers
- 5y agoFTRPField Trip Health Ltd. Continues Expansion With Psychedelic-Assisted Therapy Centers in Seattle, Vancouver and FrederictonGlobeNewswireTORONTO, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (NASDAQ:FTRP, TSX:FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today the opening of their Seattle clinic, their sixth in the
- 5y agoAWKNFBETRFBMBIFCYBN+16KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand ViewingPR NewswireNEW YORK, Oct. 18, 2021 /PRNewswire/ -- Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the presentations from the KCSA Psychedelics Virtual Investor Conference are now available for on-demand viewing.
- 5y agoFTRPField Trip Health Ltd. To Present At The KCSA Psychedelics Virtual Investor Conference On October 13thPR NewswireTORONTO, Oct. 12, 2021 /PRNewswire/ -- Field Trip Health Ltd. (TSX:FTRP, FTRP.WT, NASDAQ:FTRP) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, today announced that Joseph del Moral, Co-Founder & CEO of Field Trip, will
- 5y agoATAICMPSCYBNFTRP+1Strong Pipeline of Drugs for Treatment Of Psychotic Disorders Anticipated To Drive The Market Through 2028PR NewswirePALM BEACH, Fla., Oct. 11, 2021 /PRNewswire/ -- There is a high demand for more advanced products for the treatment and maintenance of severe mental disorders. Thus, pharmaceutical companies are investing a huge amount of money for novel drug R&D and l
- 5y agoFTRPField Trip Health Announces Voting Results From the Annual General and Special Meeting of ShareholdersGlobeNewswireTORONTO, Sept. 24, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX:FTRP, FTRP.WT, NASDAQ:FTRP) ("Field Trip"), today announced the voting results from its Annual General and Special Meeting of Shareholders held on Friday, September 24, 2021. A t
- 5y agoFTRPField Trip Health Ltd. to Participate in Four Investor Conferences in SeptemberGlobeNewswireTORONTO, Sept. 10, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX:FTRP, FTRP.WT, NASDAQ:FTRP) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, today announced it will participate in the H.C. Wainwright 23rd Annua
- 5y agoFTRPField Trip Health Ltd. to Pursue Treatment Resistant Depression and Postpartum Depression as Indications for FT-104GlobeNewswireTORONTO, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX:FTRP, FTRP.WT, NASDAQ:FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today the lead indications for FT-104, its novel psy
- 5y agoFTRPField Trip Health Ltd. Announces Launch Of "Kap Co-Operative" Program, Enabling Independent Psychedelic Therapists To Practice At Its Field Trip Health Centers; Also Launches Training Programs To Educate A New Generation Of Psychedelic CliniciansGlobeNewswireThe KAP Co-op program gives eligible therapists the ability to provide ketamine-assisted psychotherapy (KAP) to their patients at Field Trip Health Centers utilizing Field Trip's medical teams for screening, prescribing and administration of ketamine.
- 5y agoFTRPField Trip Health Ltd. Reports Fiscal First Quarter 2022 Financial ResultsGlobeNewswireAt June 30, 2021 had approximately $100 million in unrestricted cash and cash equivalents, funds held in trust and short-term investments Development of FT-104, a novel psychedelic molecule with pending patents, continues to progress with GMP productio
- 5y agoFTRPField Trip Health Ltd. Schedules First Fiscal Quarter 2022 Financial Results Conference Call for Tuesday, August 17, 2021 at 8:30 am ETGlobeNewswireTORONTO, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX:FTRP, FTRP.WT, NASDAQ:FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that it plans to release financial results for